#keytruda
Moderna Cancer Vaccine Hits Major Phase 3 Melanoma Milestone
Moderna and Merck announced positive late-stage melanoma trial results on Wednesday, August 19. The Phase 3 study involved 1,137 patients with surgically removed high-risk stage IIB to IV melanoma. Moderna Cancer Vaccine meets key Phase 3 melanoma goals Moderna and Merck have reported a major clinical milestone for their personalised mRNA cancer therapy after the Phase 3 INTerpath-001 trial met its primary and key secondary endpoints in patien
Moderna Cancer Vaccine Hits Major Phase 3 Melanoma Milestone
Moderna and Merck announced positive late-stage melanoma trial results on Wednesday, August 19. The Phase 3 study involved 1,137 patients with surgically removed high-risk stage IIB to IV melanoma. Moderna Cancer Vaccine meets key Phase 3 melanoma goals Moderna and Merck have reported a major clinical milestone for their personalised mRNA cancer therapy after the Phase 3 INTerpath-001 trial met its primary and key secondary endpoints in patien









